One of my recent purchases for my Covestor Healthcare Model is Medtronic, Inc. (MDT). I purchased shares May 1, 2013, at an effective cost of $47.00.

Medtronic, Inc. : First-of-Its-Kind Independent Review of INFUSE� Bone Graft Coordinated by Yale University is Complete.

Medtronic, Inc. (NYSE:MDT) As the market becomes more volatile and high-grade dividend stocks begin to fall in price an opportunity opens up to buy those stocks at a more reasonable price than the last few months have offered.

Medtronic Inc. (MDT) Medtronic Inc. at Goldman Sachs Healthcare Conference June 11, 2013 6:20 PM ET. David Roman. So, we'll go ahead and get started.

VANCOUVER - June 14, 2013 - Medtronic, Inc. (NYSE: MDT) today presented baseline characteristics of patients enrolled in the Extreme Risk Study of the Medtronic CoreValve U.S.

NICE, France - June 13, 2013 - Medtronic, Inc. (NYSE: MDT) announced today the CE Mark (Conformit� Europ�enne) and the European launch of the ReDuX(TM) Plier, a new instrument specially designed for use during osteotomies.

MINNEAPOLIS - June 13, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Wells Fargo Securities 2013 Healthcare Conference on Tuesday, June 18, 2013, in Boston.

(RTTNews.com) - Medtronic Inc ( MDT ) will present at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, CA,.

Research and Markets (http://www.researchandmarkets.com/research/b6p7gd/medtronic_inc) has announced the addition of the "Medtronic, Inc. Market Share Analysis" company profile to their offering. This report provides in-depth information on Medtronic, ...

Wedbush initiated coverage on Medtronic, Inc. (NYSE: MDT) with a Neutral rating and a price target of $52.00. Analyst Tao Levy expressed concern about valuation.